USPTO serial 79381831
Serial No. 79381831
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- CORNWELL, ANDREA B
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79381831?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Harris A. Wolin
Harris A. Wolin Myers Wolin, LLC100 South Jefferson Road, Suite 202Innovation WayWhippany, NJ 07981-1009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for use in genetic and epigenetic research and biochemical analysis, other than for medical or veterinary purposes; chemical diagnostic reagents for clinical, medical laboratory research, scientific or research use, other than for medical or veterinary purposes; reagents for pharmaceutical research; genetic identity tests comprised of reagents for non-medical purposes; substances for use in genetic and epigenetic probe assay kits, not for medical use, namely, assays and reagents for use in genetic research; chemical reagents for non-medical purposes in the field of genetic identity testing; chemical preparations for scientific use in non-medical nucleic acid analysis; biochemicals, namely, precursors for in vitro and in vivo genetic engineering and scientific use; diagnostic preparations for scientific or research use; catalysts for use in chemical and biochemical processes; reagents for scientific purposes for use in nucleic acid characterisation and nucleic acid sequencing; nucleic acid sequences, other than for medical or veterinary use ; reagents for scientific purposes for protein identification and analysis; nucleic acids, other than for medical or veterinary purposes; oligonucleotides for scientific and research use; oligosaccharides for scientific and research use; proteins in the nature of protein arrays for scientific and medical research; peptide substrates for scientific purposes; chemicals, enzymes and reagents for scientific purposes for use in genome, DNA, RNA and nucleic acid synthesis; nucleic acid amplification reagents, other than for medical or veterinary use ; unprocessed polymers for use in the analysis of nucleic acids; nucleic acid reagents for use in forensic analysis, other than for medical or veterinary purposes ; monoclonal and polyclonal antibody reagents, other than for medical or veterinary use; reagents for research purposes; reagents for scientific purposes; reagents for medical research; diagnostic reagents for in-vitro use, other than for medical or veterinary purposes ; reagents for laboratory research use; reagents for scientific use in the fields of molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification, other than for medical or veterinary purposes; reagents for use in forensic analysis, other than for medical or veterinary purposes; reagents for blood grouping, other than for medical or veterinary purposes; proteases in the nature of enzymes for scientific and research purposes; nucleases in the nature of enzymes for scientific and research purposes, including RNase, DNase and restriction enzymes; proteins in raw material form for scientific and medical research purposes, namely, for use in analytical tests; reagents for medical and veterinary research; nucleic acid amplification reagents for veterinary research, medical research or scientific forensic use; reagents for protein identification and analysis, other than for medical or veterinary purposes; reagents for medical and veterinary research | ACTIVE | — |
| 005 | Genetic identity tests comprised of reagents for medical purposes; preparations for detecting genetic and epigenetic predispositions for medical purposes; reagents for use in medical genetic and epigenetic testing; reagents for medical and veterinary diagnosis; reagents for laboratory tests for medical or veterinary purposes; reagents for medical purposes, namely, for use in blood grouping, molecular biology, bacteriological, biotechnology and microbiological analysis; chemical preparations for medical use in nucleic acid analysis; nucleic acid sequences for medical and veterinary purposes; reagents for medical use, namely, for use in nucleic acid characterisation and nucleic acid sequencing; proteins in the nature of protein arrays for use in tests for medical or veterinary diagnosis purposes | ACTIVE | — |
| 009 | Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; scientific measuring apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; laboratory apparatus and instruments for extracting nucleic acid and DNA, not for medical purposes; laboratory instruments for use in genetic and epigenetic analysis and research; laboratory instruments for scientific research, namely, anomoly detectors for genetic, epigenetic, and biochemical analysis; scientific apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid, molecular, optical, electrochemical, magnetic force, electromechanical force, or mechanical force analysis, and measurement of ions, namely, digital force gauges, spectrophotometer for measuring relative DNA, RNA and protein; medical laboratory research apparatus and instruments for DNA, RNA, protein and polynucleic acid analysis, namely, for use in DNA, RNA, protein and polynucleic acid sequencing; medical laboratory research apparatus for the analysis of polynucleic acid sequences; medical laboratory research apparatus and instruments for the analysis of proteins, nucleic and polynucleic acids, genetic and epigenetic information, genomic and epigenomic information and proteomic information; apparatus and instruments for use in laboratory analysis, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for laboratory research uses; monitoring apparatus and instruments, namely, electronic monitors and monitor modules for monitoring electric current and electrical signals; downloadable and recorded computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides, namely, laboratory devices for detecting genetic sequences, nucleic acid sequencers for scientific purposes; data processing apparatus, and equipment; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides, namely, laboratory devices for detecting genetic sequences, nucleic acid sequencers for scientific purposes; laboratory instruments for use in genetic and epigenetic fingerprinting, genetic and epigenetic sequencing, genetic and epigenetic information extraction, namely,laboratory devices for detecting genetic sequences, nucleic acid sequencers for scientific purposes; laboratory instruments for use in genetic and epigenetic fingerprinting, genetic and epigenetic sequencing, genetic and epigenetic information extraction, namely, laboratory devices for detecting genetic sequences, nucleic acid sequencers for scientific purposes; genetic and epigenetic analysis and testing devices and apparatus for laboratory use and research, namely, laboratory devices for detecting genetic sequences, nucleic acid sequencers for scientific purposes; diagnostic and testing apparatus for research laboratory use for detecting pathogens, DNA analysis, thermal imaging; imaging, electrochemical, electromechanical, and mechanical devices used for analysing nucleic acids, namely, research laboratory analyzers for measuring, testing and analyzing nucleic acids; devices for analysing protein sequence used as laboratory apparatus; teaching apparatus and instruments, namely, teaching robots, medical diagnostic simulators for use as teaching aids for genetic sequencing; biometric identification apparatus; nucleic acid sequencers for scientific purposes; testing apparatus incorporating chemical or biological reagents, namely, laboratory chemical reactors; reaction units containing chemical or biological reagents in the nature of reaction systems for catalyst research; flow cell cartridges specially adapted to flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses; flow cytometers and flow-based analysers providing cell and particle analysis, detection, or counting for scientific and laboratory research; magnets, magnetizers and demagnetizers for scientific use; magnetic separators for scientific use; downloadable and recorded computer software for operating research laboratory equipment; downloadable and recorded computer software for molecular analysis; downloadable and recorded computer software for the analysis of genetic and epigenetic sequences; downloadable and recorded computer software for genetic and epigenetic analysis; downloadable and recorded software for use in analysing, transmitting and receiving data via a global communications network; downloadable and recorded software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; downloadable and recorded computer operating system software; downloadable and recorded operating system software for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments, namely surgical apparatus and instruments for medical, dental or veterinary use; medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis, namely, apparatus for DNA and RNA testing for medical purposes, apparatus for blood analysis; clinical and medical diagnostic instruments, namely, nucleic acid sequencers for medical purposes; genetic and epigenetic testing apparatus for medical purposes; diagnostic apparatus and instruments for medical purposes, namely, for testing DNA and RNA samples; apparatus for medical cell sampling, namely, sample preparation device for medical diagnostic uses; blood testing apparatus; testing apparatus for medical or veterinary purposes; cartridges for test samples, specially adapted to flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical purposes; reaction units containing chemical reagents, for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; nanopore sensing devices in the nature of apparatus for DNA and RNA testing for medical purposes; fluorescence sensing devices in the nature of medical instruments for measuring and displaying concentrations of pH, O2, pCO2, glucose, and calcium in blood; ion sensing devices in the nature of medical instruments for measuring and displaying blood concentrations | ACTIVE | — |
| 042 | Scientific services, namely, DNA analysis services for scientific research purposes, and scientific and technological research and design in the field of DNA analysis technology; scientific laboratory services; laboratory testing services, namely, laboratory testing of materials; medical laboratory services; research laboratory analysis services in the field of bacteriology, chemistry, cosmetics; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary research purposes; scientific research relating to genetics; scientific research and development in the field of genetics and genetic engineering; laboratory research in the field of genetic analysis; genetic research for scientific purposes; genetic fingerprinting; genetic sequencing in the nature of genetic mapping for scientific purposes; engineering services in the field of genetics; genetic and epigenetic information extraction from biological samples in the nature of providing genetic science information; biological research and analysis; biochemical research and analysis; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific research purposes; scientific laboratory services relating to the synthesis of chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; research and development in the field of biotechnology; nucleic acid testing services in the nature of scientific laboratory services; nucleic acid screening for scientific research purposes; nucleic acid fingerprinting in the nature of genetic fingerprinting services; nucleic acid sequencing in the nature of genetic mapping for scientific purposes; epigenetic analysis of nucleic acids for scientific research purposes; genome, DNA, RNA and nucleic acid, oligosaccharide, protein and peptide synthesising services in the nature of scientific laboratory services; DNA and RNA and polynucleic acid sequencing, analysis and evaluation services in the nature of scientific laboratory and research services; genome and protein sequencing services in the nature of scientific laboratory services;; DNA and polynucleic acid testing services in the nature of scientific laboratory services; conducting sampling and analysis services for laboratory purposes in the nature of providing reagent sample testing and diagnostic services for others for scientific research purposes; genetic sample preparation and analysis for laboratory purposes in the nature of scientific laboratory services; analysis and evaluation of data, including scientific and medical data, in the nature of structural and functional analysis of genomes; DNA analysis services for scientific research purposes, namely, provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; preparation of biological samples for analysis in laboratories in the nature of scientific laboratory services; biochemical research, analysis and development; rental of laboratory apparatus and instruments; product design and development of laboratory apparatus and equipment for genetic analysis and testing; product design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; product design and development of diagnostic apparatus, equipment and instruments; development of computer programs for biotechnological applications; drug discovery services; pharmaceutical drug development services for others; pharmaceutical drug development services; research and development of medicines; research and development of vaccines; genetic testing of laboratory animals for research purposes; toxicology research services; consulting services in the field of genetic toxicology research services; design and development, updating, and installation of computer software for use in the field of molecular analysis; platform as a service (PaaS) featuring computer software platforms for conducting genetic analysis; platform as a service (PaaS) featuring computer software platforms for conducting genome analysis and genetic sequencing; design and development of computer platforms; design and development of software technology for genome analysis; design and development, updating, and installation of computer software for use in the field of genetic analysis;; hosting computer software platforms on the Internet for use in the field of molecular analysis; information, advisory and consultancy services relating to all the aforesaid; scientific laboratory services for the provision of scientific analysis | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes related to samples taken from patients, provided by medical laboratories; DNA and RNA screening for medical purposes; medical and health care services relating to DNA, RNA, genetics, epigenetics, genetic testing, and epigenetic testing; genetic and epigenetic testing for medical purposes, analysis and reporting for medical diagnosis and prognosis; nucleic acid sequencing and analysis services in the nature of genetic testing for medical purposes; medical diagnostic services; rental of medical equipment, namely, diagnostic apparatus; information, advisory and consultancy services in the field of medicine and health care as related to genetics, and epigenetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DEPIXUS UK LTD
- Other trademarks owned by DEPIXUS UK LTD
- Other trademarks owned by DEPIXUS UK LTD
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 31, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 31, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 25, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 18, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 12, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 12, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 5, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 4, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 16, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |